Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bower

Showing results (121-130 of 252) with videos related to

Pageof 26
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2010
Presence of monoclonal T-cell populations in B-cell post-transplant lymphoproliferative disordersHazem A H Ibrahim, Lia P Menasce, Sabine Pomplun, et al.
European Journal of Haematology|April 23, 2010
Epstein-Barr virus (EBV) genotypes among human immunodeficiency virus (HIV)-related B-cell lymphomas and B-cell post-transplant lymphoproliferative disorders (B-PTLD)--late-onset lymphomas, especially in the HIV setting, are associated with type-B-EBVHazem A H Ibrahim, Lia P Menasce, Sabine Pomplun, et al.
AIDS (London, England)|January 21, 2014
High-resolution anoscopy screening of HIV-positive MSM: longitudinal results from a pilot studyAlessia Dalla Pria, Maryam Alfa-Wali, Paul Fox, et al.
The American Journal of the Medical Sciences|January 22, 2009
Gastroenteropancreatic neuroendocrine tumors in patients with HIV infection: a trans-Atlantic seriesPiro Lito, Liron Pantanowitz, Jonathan Marotti, et al.
Blood|February 20, 2009
Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman diseaseMark Bower, Ophelia Veraitch, Richard Szydlo, et al.
AIDS (London, England)|December 4, 2008
Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individualsJohn Ns Gregson, Alan Steel, Mark Bower, et al.
Clinical Genitourinary Cancer|October 1, 2008
Human immunodeficiency virus--associated renal cell carcinoma: a transatlantic case seriesElizabeth M Gaughan, Bruce J Dezube, David Aboulafia, et al.
Blood|November 21, 2007
Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman diseaseTom Powles, Justin Stebbing, Silvia Montoto, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2005
The effect of statins on HIV rebound and blipsLaura Waters, Justin Stebbing, Rachael Jones, et al.
Cancer|February 21, 2008
Cancer vaccines: clinical development challenges and proposed regulatory approaches for patient access to promising treatmentsJustin Stebbing, Christopher Wood, Michael Atkins, et al.
Pageof 26

Showing results (121-130 of 252) with videos related to

Sort By:
Pageof 26
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2010
Presence of monoclonal T-cell populations in B-cell post-transplant lymphoproliferative disordersHazem A H Ibrahim, Lia P Menasce, Sabine Pomplun, et al.
European Journal of Haematology|April 23, 2010
Epstein-Barr virus (EBV) genotypes among human immunodeficiency virus (HIV)-related B-cell lymphomas and B-cell post-transplant lymphoproliferative disorders (B-PTLD)--late-onset lymphomas, especially in the HIV setting, are associated with type-B-EBVHazem A H Ibrahim, Lia P Menasce, Sabine Pomplun, et al.
AIDS (London, England)|January 21, 2014
High-resolution anoscopy screening of HIV-positive MSM: longitudinal results from a pilot studyAlessia Dalla Pria, Maryam Alfa-Wali, Paul Fox, et al.
The American Journal of the Medical Sciences|January 22, 2009
Gastroenteropancreatic neuroendocrine tumors in patients with HIV infection: a trans-Atlantic seriesPiro Lito, Liron Pantanowitz, Jonathan Marotti, et al.
Blood|February 20, 2009
Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman diseaseMark Bower, Ophelia Veraitch, Richard Szydlo, et al.
AIDS (London, England)|December 4, 2008
Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individualsJohn Ns Gregson, Alan Steel, Mark Bower, et al.
Clinical Genitourinary Cancer|October 1, 2008
Human immunodeficiency virus--associated renal cell carcinoma: a transatlantic case seriesElizabeth M Gaughan, Bruce J Dezube, David Aboulafia, et al.
Blood|November 21, 2007
Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman diseaseTom Powles, Justin Stebbing, Silvia Montoto, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2005
The effect of statins on HIV rebound and blipsLaura Waters, Justin Stebbing, Rachael Jones, et al.
Cancer|February 21, 2008
Cancer vaccines: clinical development challenges and proposed regulatory approaches for patient access to promising treatmentsJustin Stebbing, Christopher Wood, Michael Atkins, et al.
Pageof 26